Cargando…

Complement in neurological disorders and emerging complement-targeted therapeutics

The complement system consists of a network of plasma and membrane proteins that modulate tissue homeostasis and contribute to immune surveillance by interacting with the innate and adaptive immune systems. Dysregulation, impairment or inadvertent activation of complement components contribute to th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalakas, Marinos C., Alexopoulos, Harry, Spaeth, Peter J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528717/ https://www.ncbi.nlm.nih.gov/pubmed/33005040 http://dx.doi.org/10.1038/s41582-020-0400-0

Ejemplares similares

The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
por: Querol, Luis A., et al.
Publicado: (2022)

GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions
por: Tsiortou, Popianna, et al.
Publicado: (2021)

Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
por: Stathopoulos, Panos, et al.
Publicado: (2022)

Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies
por: Dalakas, Marinos C., et al.
Publicado: (2022)

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Aberrant Complement System Activation in Neurological Disorders
por: Ziabska, Karolina, et al.
Publicado: (2021)

Precision Medicine in Neurology: The Inspirational Paradigm of Complement Therapeutics
por: Gavriilaki, Maria, et al.
Publicado: (2020)

Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
por: Rakocevic, Goran, et al.
Publicado: (2019)

Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Neurological complications of immune checkpoint inhibitors: what happens when you ‘take the brakes off’ the immune system
por: Dalakas, Marinos C.
Publicado: (2018)

Complement and Complement Targeting Therapies in Glomerular Diseases
por: Andrighetto, Sofia, et al.
Publicado: (2019)

IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
por: Dalakas, Marinos C.
Publicado: (2021)

Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics
por: Garred, Peter, et al.
Publicado: (2021)

Complement as a Therapeutic Target in Systemic Autoimmune Diseases
por: Galindo-Izquierdo, María, et al.
Publicado: (2021)

Emerging Roles of Complement in Psychiatric Disorders
por: Druart, Mélanie, et al.
Publicado: (2019)

Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease: More to come with myositis in the offing
por: Dalakas, Marinos C.
Publicado: (2020)

Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
por: Dalakas, Marinos C.
Publicado: (2022)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

The Complement System: A Potential Therapeutic Target in Liver Cancer
por: Yuan, Meng, et al.
Publicado: (2022)

The complement system
por: Sarma, J. Vidya, et al.
Publicado: (2010)

Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
por: Alexopoulos, Harry, et al.
Publicado: (2020)

The Emerging Role of Complement Lectin Pathway in Trypanosomatids: Molecular Bases in Activation, Genetic Deficiencies, Susceptibility to Infection, and Complement System-Based Therapeutics
por: Evans-Osses, Ingrid, et al.
Publicado: (2013)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

The Emerging Roles of Extracellular Chaperones in Complement Regulation
por: Geraghty, Nicholas J., et al.
Publicado: (2022)

The Contribution of Complement to the Pathogenesis of IgA Nephropathy: Are Complement-Targeted Therapies Moving from Rare Disorders to More Common Diseases?
por: Poppelaars, Felix, et al.
Publicado: (2021)

Complement
por: Treffers, Henry P.
Publicado: (1966)

Rationale for targeting complement in COVID‐19
por: Polycarpou, Anastasia, et al.
Publicado: (2020)

MECHANISM OF HEMOLYSIS BY COMPLEMENT : I. COMPLEMENT FIXATION AS AN ESSENTIAL PRELIMINARY TO HEMOLYSIS.
por: Eagle, Harry, et al.
Publicado: (1929)

Can Urinary Complement Proteins Stratify Patients to Therapeutic Complement Inhibitors?
por: Medjeral-Thomas, Nicholas R.
Publicado: (2022)

THE MECHANISM OF COMPLEMENT FIXATION
por: Eagle, Harry
Publicado: (1929)

Complement, a Therapeutic Target in Diabetic Kidney Disease
por: Budge, Kelly, et al.
Publicado: (2021)

Complement activation in COVID-19 and targeted therapeutic options: A scoping review
por: Lim, Endry Hartono Taslim, et al.
Publicado: (2023)

Complement Therapeutics in Autoimmune Disease
por: Thurman, Joshua M., et al.
Publicado: (2019)

Complement or Alexin
Publicado: (1937)

Targeting complement in IgA nephropathy
por: Caravaca-Fontán, Fernando, et al.
Publicado: (2023)

Targeting the complement system in pancreatic cancer drug resistance: a novel therapeutic approach
por: Hussain, Naushair, et al.
Publicado: (2022)

Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies
por: Dalakas, Marinos C.
Publicado: (2018)

Therapies in Stiff-Person Syndrome: Advances and Future Prospects Based on Disease Pathophysiology
por: Dalakas, Marinos C.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_77cj0fvjsmeq8c924213mf9jng